CHAOJU EYE CARE Executes Additional 59,000-Share Buyback; Cumulative Mandate Usage at 0.09% of Capital

Bulletin Express

Jun 16

Chaoju Eye Care Holdings Limited reported that it repurchased 59,000 ordinary shares on 16 June 2026 via on-market transactions at prices ranging from HK$2.55 to HK$2.57 per share, for a total consideration of HK$0.15 million.

Including this latest transaction, the company has repurchased 1.04 million shares between 2 April and 16 June 2026 that are pending cancellation. Of these, 659,000 shares were bought after the 12 May 2026 annual mandate and fall within the current 70.52 million-share repurchase authority—representing 0.09 % of the issued share capital at the mandate date.

Despite the buybacks, the issued share count remains unchanged at 705.18 million shares as of 16 June 2026, with no treasury shares held. Under Hong Kong listing rules, Chaoju Eye Care is subject to a moratorium on issuing new shares until 16 July 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1122426442"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1122426442\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1122426442?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-16 18:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1122426442","market":"us","top_or_hot":-1,"title":"CHAOJU EYE CARE Executes Additional 59,000-Share Buyback; Cumulative Mandate Usage at 0.09% of Capital","media":"Bulletin Express","content":"<p>Chaoju Eye Care Holdings Limited reported that it repurchased 59,000 ordinary shares on 16 June 2026 via on-market transactions at prices ranging from HK$2.55 to HK$2.57 per share, for a total consideration of HK$0.15 million.</p>\n<p>Including this latest transaction, the company has repurchased 1.04 million shares between 2 April and 16 June 2026 that are pending cancellation. Of these, 659,000 shares were bought after the 12 May 2026 annual mandate and fall within the current 70.52 million-share repurchase authority—representing 0.09 % of the issued share capital at the mandate date.</p>\n<p>Despite the buybacks, the issued share count remains unchanged at 705.18 million shares as of 16 June 2026, with no treasury shares held. Under Hong Kong listing rules, Chaoju Eye Care is subject to a moratorium on issuing new shares until 16 July 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CHAOJU EYE CARE Executes Additional 59,000-Share Buyback; Cumulative Mandate Usage at 0.09% of Capital</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCHAOJU EYE CARE Executes Additional 59,000-Share Buyback; Cumulative Mandate Usage at 0.09% of Capital\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-16 18:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Chaoju Eye Care Holdings Limited reported that it repurchased 59,000 ordinary shares on 16 June 2026 via on-market transactions at prices ranging from HK$2.55 to HK$2.57 per share, for a total consideration of HK$0.15 million.</p>\n<p>Including this latest transaction, the company has repurchased 1.04 million shares between 2 April and 16 June 2026 that are pending cancellation. Of these, 659,000 shares were bought after the 12 May 2026 annual mandate and fall within the current 70.52 million-share repurchase authority—representing 0.09 % of the issued share capital at the mandate date.</p>\n<p>Despite the buybacks, the issued share count remains unchanged at 705.18 million shares as of 16 June 2026, with no treasury shares held. Under Hong Kong listing rules, Chaoju Eye Care is subject to a moratorium on issuing new shares until 16 July 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02219","symbol_name":"朝聚眼科","start_time":0,"source_url":"","article_id":"1122426442","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1122426442","pubTimestamp":1781604319,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Chaoju Eye Care Holdings Limited reported that it repurchased 59,000 ordinary shares on 16 June 2026 via on-market transactions at prices ranging from HK$2.55 to HK$2.57 per share, for a total...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02219":"朝聚眼科"},"translate_title":"朝聚眼科执行额外5.9万股回购；累计授权使用率为资本的0.09%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02219":1},"content_text":"Chaoju Eye Care Holdings Limited reported that it repurchased 59,000 ordinary shares on 16 June 2026 via on-market transactions at prices ranging from HK$2.55 to HK$2.57 per share, for a total consideration of HK$0.15 million.\nIncluding this latest transaction, the company has repurchased 1.04 million shares between 2 April and 16 June 2026 that are pending cancellation. Of these, 659,000 shares were bought after the 12 May 2026 annual mandate and fall within the current 70.52 million-share repurchase authority—representing 0.09 % of the issued share capital at the mandate date.\nDespite the buybacks, the issued share count remains unchanged at 705.18 million shares as of 16 June 2026, with no treasury shares held. Under Hong Kong listing rules, Chaoju Eye Care is subject to a moratorium on issuing new shares until 16 July 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}